Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MTNB Relative to the S&P 500

MTNB Relative to the Sector

% of Revenue Generated in Each Quarter

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Matinas BioPharma Holdings, Inc. (AMEX:MTNB) seasonal charts above shows that a Buy Date of August 17 and a Sell Date of December 2 has resulted in a geometric average return of 2.03% above the benchmark rate of the S&P 500 Total Return Index over the past 10 years. This seasonal timeframe has shown positive results compared to the benchmark in 8 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 10 years by an average of 41.41% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm’s pipeline includes MAT2203, MAT2501, and others.

To download MTNB seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MTNB